MyFinsight
Home
Blog
About
Back
Income Statement
Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. (NVCT)
source: myfinsight.com
Total net gain
attributable to common...
-$7,020K
Net loss
-$7,020K
(-10.83%↓ Y/Y)
Finance income
$177K
(-32.18%↓ Y/Y)
Operating loss
-$7,197K
(-9.13%↓ Y/Y)
Research and development
$4,684K
(29.64%↑ Y/Y)
General and
administrative
$2,513K
(-15.73%↓ Y/Y)
Back